Report Highlights

Industrial Hemp in the US: Market Overview

The U.S. industrial hemp market is defined by a federal legal framework that separated hemp from marijuana under the Agriculture Improvement Act of 2018, setting the threshold at 0.3 percent delta-9 THC on a dry weight basis. The market was valued at USD 1.85 billion in 2024 and is driven by cannabinoid extracts, food-grade hemp seed and fiber, rather than the grain and fiber commodity crops that dominate Canadian and European production. Unlike most global hemp markets, the U.S. hosts a large consumer wellness segment sold through convenience stores, specialty retail and online platforms that operate outside traditional agricultural distribution channels.

Structurally, the market is fragmented and volatile. Thousands of licensed growers, registered under the USDA Domestic Hemp Production Program or approved state plans, supply a processing base concentrated in a few states, while extraction capacity expanded faster than demand after 2019. Price declines in cannabinoid isolate and distillate between 2021 and 2024 compressed farmgate returns, leaving seed and fiber as the most stable revenue lines. Investors entering the U.S. therefore face a market where value depends on compliance status and processing access more than on acreage.

Growth Drivers in US Hemp

Federal and state programmes anchor demand. The 2018 Farm Bill allowed hemp to be grown as an agricultural commodity, and the USDA final rule under 7 CFR Part 990, effective March 2021, created a federal licensing channel that lets producers sell across state lines. Hulled hemp seed has been recognised as a food ingredient through FDA good-faith GRAS determinations, which has supported growth in protein powders, snack bars and plant-based dairy alternatives sold through national grocers.

Industrial fiber and construction demand creates a second driver. Hempcrete and hemp fiber insulation are gaining specification interest from builders pursuing low-embodied-carbon materials, and federal building decarbonisation programmes funded under the Inflation Reduction Act have widened the addressable pool for bio-based inputs. Demographic factors also matter: consumers aged 25 to 44 account for the largest share of hemp food and wellness purchases, and this cohort is shifting household spending toward plant-based products with functional positioning.

Market Restraints and Entry Barriers

The FDA does not recognise CBD as a lawful dietary supplement or food additive, which forces companies to market cannabinoid products without health claims and exposes them to enforcement risk under the Federal Food, Drug, and Cosmetic Act. Several states, including Texas and Ohio, require product registration, batch certificates of analysis and labelling approval before sale, and these rules differ state by state. New entrants face a patchwork of compliance costs that favours established brands with multi-state legal teams.

Production licensing imposes strict testing obligations. Under the USDA framework, a crop that tests above the permitted THC threshold must be destroyed, and producers bear that loss without federal crop assistance. Incumbents such as Charlotte's Web and cbdMD hold retail shelf space and consumer brand recognition, while the 2025 appropriations restrictions on intoxicating hemp products add uncertainty to distribution contracts signed before the November 2026 deadline.

Market Opportunities in the US

Hemp seed protein and food ingredients represent the nearest entry opportunity. U.S. hemp seed and hemp hearts sales are estimated at USD 210 million in 2025, and private label supply to national grocers and natural foods distributors remains underpenetrated. Processors that hold FDA-compliant ingredient documentation can secure multi-year supply agreements with plant-based food manufacturers in the Midwest and Pacific Northwest, where processing demand is concentrated.

Fiber processing and hemp building materials offer a second opening. Addressable demand for hemp hurd and fiber in U.S. hempcrete and insulation applications is estimated at USD 110 million in 2025, and supply remains largely imported from Canada and Europe. Entrants that invest in decortication and seed-cleaning capacity in Kentucky, Colorado, Texas and North Carolina can supply regional building projects while capturing state agricultural development grants.

Market at a Glance

Leading Market Participants

• Charlotte's Web Holdings
• cbdMD
• Panacea Life Sciences
• Elixinol Wellness
• Generation Hemp
• Arcadia Biosciences
• Manitoba Harvest
• Tilray Brands
• Hemp Synergistics
• Veritas Farms

Regulatory and Policy Environment

The Agriculture Improvement Act of 2018 (Public Law 115-334) removed hemp from the Controlled Substances Act and assigned production oversight to the USDA Agricultural Marketing Service. Producers must be licensed under the Domestic Hemp Production Program, either federally or through a USDA-approved state plan, and must submit sampling and testing records. Federal crop insurance for hemp is administered by the USDA Risk Management Agency, providing a partial financial backstop for licensed growers.

The FDA oversees hemp-derived ingredients and consumer products under the Federal Food, Drug, and Cosmetic Act, and agency guidance continues to restrict CBD in food and supplements. The November 2025 federal appropriations law redefined hemp to exclude intoxicating products above prescribed container-level THC limits, with enforcement effective in November 2026. Companies must complete product reformulation, state re-registration and inventory transitions within that twelve-month window to remain in compliance.

Long-Term Outlook for US Hemp

By 2032, the U.S. industrial hemp market is forecast to reach USD 3.12 billion, with growth weighted toward food-grade seed, protein ingredients and bio-based construction inputs. The cannabinoid segment will shrink as a share of total revenue after federal restrictions take full effect, and processors with diversified seed and fiber lines will hold the strongest margins. Consolidation among extraction and processing businesses will accelerate as smaller operators exit.

Supply chains will regionalise around processing hubs in Kentucky, Colorado and Texas, reducing dependence on Canadian fiber imports. Federal regulatory clarity on hemp-derived ingredients will determine whether the consumer wellness segment expands into mainstream grocery channels or remains confined to specialty retail. Buyers who secure compliant supply and processing access early will hold a durable advantage through the forecast period.